Guangdong Zhonghao Pharmaceutical Co. Ltd.

评价本维莫德乳膏治疗轻中度特应性皮炎的有效性和安全性

评价本维维莫德乳膏用于轻中度寻常型银屑病长期（间歇）治疗的有效性和安全性

This is a retreatment, multicenter, randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of Benvitimod cream, 1% twice daily for the retreatment of mild to moderate stable psoriasis vulgaris in adults. Approximately 390 participants with mild to moderate stable psoriasis vulgaris will be enrolled and randomly divided into two groups in a 2:1 ratio. They will use either the Benvitimod cream or placebo at the skin with psoriasis vulgaris for 12 weeks.